stars 1 stars 2 stars 3

MGC Diagnostics Australia began its operations in the Australasian market in 2006. The company is now considered one of the premier providers of Cardio-Respiratory instrumentation. Our management team embodies over 45 years of global expertise including affiliations with over 50 global healthcare distributors spanning six continents. Our Committment To Our Customers: SERVICE – To set and maintain a new benchmark in Customer Care for Sleep, Rehabilitation & Cardiopulmonary Diagnostics INNOVATION – To bring new and innovative medical devices to Australasia in response to the needs of its Healthcare Community SCIENCE - To advance the level of Science & Technology for diagnostic services CHOICE – To broaden the choice & competition in the Australasian marketplace VALUE – To raise the standard for Quality, Science and Customer Service whilst lowering the ‘total cost-of-ownership’ (TCO) for medical equipment in Australasia. OUR MISSION: To facilitate sustainable and profitable technology transfer between manufacturers and healthcare providers to maximise patient outcomes

Ascencia Questions

The Ascencia annual revenue was $40.5 million in 2026.

Michael Panagopoulos is the Managing Director of Ascencia.

8 people are employed at Ascencia.

Ascencia is based in Dandenong South, Victoria.

The NAICS codes for Ascencia are [33, 339].

The SIC codes for Ascencia are [384, 38].

Top Ascencia Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users